prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, FINAL DIAGNOSIS: BREAST. RIGHT, MODIFIED RADICAL MASTECTOMY AND AXILLARY DISSECTION -. A. INFILTRATING MAMMARY CARCINOMA (A, B, C, D, E, F, G and N). THE INVASIVE TUMOR COMES TO WITHIN. LESS THAN 1.0 MM FROM THE UPPER INNER DEEP RESECTION MARGIN (E) AND IS ABOUT 1.0 MM AWAY. FROM THE JUNCTION OF UPPER INNER AND UPPER OUTER DEEP RESECTION MARGIN (D) (see comment). B. THE TUMOR SIZE IS 4.3 x 3.2 x 2.2 CM. C. NOTTINGHAM SCORE: 6/9 (TUBULES - 3, NUCLEI - 2, MITOSIS - 1). D. LYMPHOVASCULAR INVASION IS NOT APPRECIATED. E. MARGINS OF RESECTION ARE FREE OF TUMOR. F. NIPPLE, WITH TUMOR INVOLVING DEEP DERMIS (A). G. SKIN WITH SEBORRHEIC KERATOSIS, NO TUMOR IS SEEN. H. CHANGES CONSISTENT WITH THE PREVIOUS CORE BIOPSY SITE, SEE PRIOR. I. ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA. J. FIBROCYSTIC CHANGES WITH DUCT ECTASIA AND DUCTAL EPITHELIAL HYPERPLASIA. K. MEDIAL CALCIFICATION OF BLOOD VESSELS. L. METASTATIC ADENOCARCINOMA INVOLVING TWO (2) (W AND AA, BB) OUT OF SEVENTEEN (17) RIGHT. AXILLARY LYMPH NODES, UP TO 6.0 CM WITH EXTRACAPSULAR EXTENSION, UP TO 4.0 CM (AA AND BB) (see. comment). M. IMMUNOHISTOCHEMICAL STAINING FOR ESTROGEN RECEPTOR, PROGESTERONE RECEPTOR, AND HER-. 2/neu WERE PREVIOUSLY PERFORMED ON. AND WERE REPORTED AS FOLLOWS: ESTROGEN. RECEPTOR - POSITIVE, PROGESTERONE RECEPTOR - NEGATIVE, AND HER-2/neu - NEGATIVE (SCORE: 0). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Modified radical mastectomy. Upper outer quadrant. Upper inner quadrant. Lower outer quadrant. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 43 mm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Ductal adenocarcinoma, NOS, Infiltrating lobular carcinoma, Other Type(s): Predominently lobular-90% with focal 10% ductal. HISTOLOGIC TYPE: Classical, Alveolar. NOTTINGHAM SCORE: Nuclear grade: 2. Tubule formation: 3. Mitotic activity score: 1. Total Nottingham score: 6. Nottingham grade (1, 2, 3): 2. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: Yes, benign zones. critcria Diagnosils. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Primary HiPAA Malignancy. Prior Primary. PAGET'S DISEASE OF NIPPLE: LYMPH NODES POSITIVE: 2. case Reviewer is (circle): Initials Date previewed. LYMPH NODES EXAMINED: 17. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain. SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 60.0 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Yes, Maximum size is:40.0mm. NON-NEOPLASTIC BREAST TISSUE: ADH, FCD. T STAGE, PATHOLOGIC: pT2. N STAGE, PATHOLOGIC: pN1. M STAGE: Not applicable. ESTROGEN RECEPTORS: positive. PROGESTERONE RECEPTORS: negative. HER2/NEU: 0.

expanded version (tokens=1389) : 
 The breast pathology report provides the following information:

1. Histological classification: 
- Subtype LumA (type of breast cancer) 
- Infiltrating ductal carcinoma NOS (90% lobular subtype with focal 10% ductal)

2. Tumor size: 4.3 x 3.2 x 2.2 cm

3. Nottingam score: 6/9 (Tubules - 3, Nuclei - 2, Mitosis -1); Nottingham grade: 2 

4. Lymphovascular invasion: not appreciated

5. Margins: Resection margins are free of tumor

6. Necrosis: not mentioned

7. Tumor infiltrating lymphocytes: not mentioned

8. Calcification: benign zones are seen 

9. Receptor status and IHC: ER-positive, PR-negative, HER2/neu negative (score: 0)

10. Ancillary testing results: 
- Two (2) out of seventeen (17) right axillary lymph nodes have metastatic adenocarcinoma with extracapsular extension (maximum size is 6.0 cm with AA and BB up to 4.0 cm). 
- Immunohistochemical staining for ER (Positive), PR (Negative), and HER2/neu (Negative) were previously performed.
- Atypical ductal epithelial hyperplasia and fibrocystic changes with duct ectasia and ductal

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1575) : 
 Subtype LumA, invasive ductal carcinoma NOS with lobular subtype seen in 90%. Tumor size 4.3 cm; Nottingham score 6/9 (grade 2). Lymphovascular invasion not present; margins free of tumor. ER-positive, PR-negative, HER2/neu negative, Calcification present (benign zones). Two out of seventeen right axillary lymph nodes show metastatic adenocarcinoma with extracapsular extension (maximum size 6.0cm with AA and BB up to 4.0cm). Atypical ductal epithelial hyperplasia noted along with fibrocystic changes and duct ectasia.

